Aug 08, 2026 — Digital Edition
Gerald Ideas
Independent Journalism & Insight
Feature

Oncology Letters. trends worth trying

Oncology Letters

Oncology Letters
Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology .

Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology .

Oncology Letters

Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression

Explore Oncology Letters , featuring peer‑reviewed articles, clinical studies, and the latest medical research.

Explore the current issue of Oncology Letters , featuring original peer-reviewed articles, clinical studies, and the latest research.

Downregulation of BKCa inhibits prostate cancer cell proliferation
Downregulation of BKCa inhibits prostate cancer cell proliferation

Useful Notes on Oncology Letters

This monthly, peer-reviewed journal focuses on all aspects of clinical oncology , as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease.

Oncology Letters is a monthly peer-reviewed medical journal covering all aspects of oncology . It was established in 2010 and is published by Spandidos Publications, with an impact factor of 3.11.

Prostate Cancer Progression and the Epigenome
Prostate Cancer Progression and the Epigenome

Oncology Letters (IF)SCI

Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology , as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease. The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology , chemotherapy ...

Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology , as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease. The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology , chemotherapy ...

Frontiers
Frontiers

Oncology Letters Impact Factor 2026

Oncology Letters current release and JCR quartile Oncology Letters's newest impact factor is 2.1, released June 17, 2026 and based on 2025 citation data. The journal is listed as JCR Q3 in this Journal Metrics record. Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues. If you searched for ...

Prostate cancer initiation progression and metastasis to bone
Prostate cancer initiation progression and metastasis to bone
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1
Model of prostate cancer progression Morphologic features of different
Model of prostate cancer progression Morphologic features of different
downregulation of septin5 inhibits prostate cancer progression by
downregulation of septin5 inhibits prostate cancer progression by
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression
PDF Cytomegalovirus infection is common in prostate cancer
PDF Cytomegalovirus infection is common in prostate cancer
PDF Downregulation of SEPTIN5 inhibits prostate cancer progression
PDF Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression

08期刊总结 Oncology Letters 是一本肿瘤学领域对国人比较友好的期刊,该刊国人占比很高,也进入过中科院预警。但也能看出该刊正在逐渐进步,降低年发文量的同时,又在尽可能控制国人发文比,该领域对该刊感兴趣的学者可以继续观望此刊。